MYL

Mylan Inc. News Headlines

$51.74
*  
0.35
0.68%
Get MYL Alerts
*Delayed - data as of Jul. 22, 2014 10:33 ET  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Will Gilead (GILD) Disappoint in Q3? - Analyst Blog
10/28/2013 12:10:01 PM - Zacks.com

Is Biogen (BIIB) Poised to Beat Earnings Estimates? - Analyst Blog
10/25/2013 6:39:01 PM - Zacks.com

Will Merck's (MRK) Earnings Streak End? - Analyst Blog
10/25/2013 6:07:06 PM - Zacks.com

Benzinga Weekly Preview: FOMC Meeting Closely Watched
10/25/2013 4:18:39 PM - Benzinga

Scott Black's Top Five Third Quarter Holdings
10/22/2013 7:06:21 PM - GuruFocus

4 Pharma Stocks Set to Deliver Earnings Surprises - Earnings ESP
10/22/2013 1:07:07 PM - Zacks.com

Will Alexion's (ALXN) Earnings Streak End? - Analyst Blog
10/22/2013 12:00:01 PM - Zacks.com

Will Celgene's (CELG) Earnings Streak End? - Analyst Blog
10/21/2013 11:09:01 AM - Zacks.com

Actavis Challenges Suboxone Film Patent - Analyst Blog
10/9/2013 11:28:08 AM - Zacks.com

A Look at Actavis' Acquisitions - Analyst Blog
10/8/2013 7:15:01 PM - Zacks.com

Forest's Patent Infringement Lawsuits - Analyst Blog
10/7/2013 1:30:01 PM - Zacks.com

S&P Winners Broadly Held by Billionaires
10/6/2013 4:30:46 PM - GuruFocus

Generic Launch at Mylan - Analyst Blog
10/1/2013 11:30:01 AM - Zacks.com

Gilead Back to Neutral - Analyst Blog
9/30/2013 2:30:01 PM - Zacks.com

Actavis a Step Closer to WCRX - Analyst Blog
9/30/2013 1:20:01 PM - Zacks.com

Update on Mylan's Generic Unit - Analyst Blog
9/30/2013 11:42:20 AM - Zacks.com

Encouraging Pipeline Data from BioMarin - Analyst Blog
9/30/2013 11:40:01 AM - Zacks.com

Insiders Are Selling Actavis
9/23/2013 11:23:00 AM - Seeking Alpha

Drug Firm Actavis Eyes Growth From A Buyout, Lidoderm
9/19/2013 8:02:00 AM - Investor's Business Daily

Biotechs In Nasdaq 100 Recap
9/17/2013 8:17:00 AM - Seeking Alpha

Mylan Pursues Global Generics Dominance Strategy
9/6/2013 9:46:00 AM - Seeking Alpha

Good News for Mylan from India - Analyst Blog
9/4/2013 4:35:01 PM - Zacks.com

TEVA Should Embrace Copaxone Patent Expiration
9/3/2013 4:26:00 PM - Seeking Alpha

Cramer's Lightning Round - New Residential Is A Taper Nightmare (8/27/13)
8/28/2013 5:58:00 AM - Seeking Alpha

Good News for Mylan's Generic Unit - Analyst Blog
8/23/2013 11:34:07 AM - Zacks.com